Skip to content

Determining the gut bacteria in the setting of high blood pressure

Determining the gut microbiota in normotensive and hypertensive patients with ambulatory blood pressure

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12620000958987
Enrollment
70
Registered
2020-09-25
Start date
2016-10-20
Completion date
2018-04-03
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

High blood pressure, also known as hypertension, is a disease where the blood inside the heart and blood vessels is pumped with more force than normal. This adds stress to these important tissues, increasing the chance of a heart attack, stroke and, as we age, heart failure. Hypertension affects one in three people in Australia, and is known as a ‘silent disease’ as it usually does not produce any symptoms until it might be too late. It is well known that our diet influences the risk to high blood pressure. While salt intake is associated with higher blood pressure, consumption of fruit, vegetables and other food rich in fibre is usually associated with lower blood pressure. New evidence from our laboratory has emerged that this may be due to the tiny microorganisms that live in our gut. While our bodies are incapable of digesting some types of fibre, they are fermented in gut, where they feed the community of ‘good’ bacteria. This results in the release of substances that can be detected in our blood and might be beneficial in lowering our blood pressure. The present study will expand our knowledge about the gut bacteria in the setting of normal and high blood pressure, to help us understand the types of bacteria present in hypertensive subjects and whether they could be contributing to the increase in blood pressure. This research has implications for cardiovascular health due to the relatively benign and cost effective nature of diet treatments. It will also inform on future intervention strategies and food guidelines.

Interventions

Participants will have blood pressure measured in the office (over 3 times, after being seated for 5 minutes) and over 24 hours with an ambulatory blood pressure device (every 15 minutes during the day and every 30 minutes during the night), will have plasma collected (once), complete a food frequency questionnaire which covers a 12 month period (The Dietary Questionnaire for Epidemiological Studies - DQES v3.2), and will self-collect one fecal sample after the 24 hours blood pressure measuremen

Participants will have blood pressure measured in the office (over 3 times, after being seated for 5 minutes) and over 24 hours with an ambulatory blood pressure device (every 15 minutes during the day and every 30 minutes during the night), will have plasma collected (once), complete a food frequency questionnaire which covers a 12 month period (The Dietary Questionnaire for Epidemiological Studies - DQES v3.2), and will self-collect one fecal sample after the 24 hours blood pressure measurement. Participants saw the principal investigator, who has more than 8 years of experience in the field, or one of the research nurses. The visit was face-to-face, and we saw each participant once (day of the visit). Equipment and fecal samples were returned to the reception of the sites. Recruitment was performed at the Alfred Hospital, Melbourne, VIC, Australia, and at the Modern Clinic, Shepparton, VIC, Australia.

Sponsors

Dr Francine Marques
Lead SponsorIndividual

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

For normotensive participants: • Diagnosis of normal blood pressure: Systolic blood pressure <140 mmHg and diastolic blood pressure <90 mmHg • Age: 40-70 years old • Gender: either • Body mass index: 18.5-30 For hypertensive participants: • Diagnosis of hypertension: Systolic blood pressure >140 mmHg and diastolic blood pressure >90 mmHg • Age: 40-70 years old • Gender: either • Body mass index: 18.5-30

Exclusion criteria

Type 1 or type 2 diabetes, chronic kidney disease, gastrointestinal diseases (including history of intestinal surgery, inflammatory bowel disease, celiac disease, lactose intolerance, chronic pancreatitis or other malabsorption disorder), use of probiotics or antibiotics in the past 3 months, and taking medication for hypertension.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026